Jürgen Fichtl, Development Characterization Pharma Technical Development, Penzberg, Germany Mass Spec 2013, September 23-26, Boston
|
|
- Pamela Tate
- 6 years ago
- Views:
Transcription
1 Analytical Strategies for Assessment of Disulfide Linkages in Biopharmaceuticals Jürgen Fichtl, Development Characterization Pharma Technical Development, Penzberg, Germany Mass Spec 2013, September 23-26, Boston
2 Introduction Example 1: bispecific MAB Method description Research Clone Results of a research clone Results of the best producing clone Example 2: MAB with open SH Determination of free thiols Comparison with RP HPLC Determination of incorrect disulfide pairing Conclusions 2
3 Introduction IGG1 3
4 Introduction What disulfid modifications may occur? open sulfhydryl groups mainly in VL and CH3 ( Lacy ER et al 2008) Basic conditions may cause the formation of a non reducable thioether between HC - LC (J. Smith et al 2005) long term storage / posttranslational modification - may cause the formation of trisulfide within all inter chain bridges (S. Gu et al 2010) Heat stress conditions -may cause scrambling of C370 $ C96 (Yi Wang et al 2011) - fragmentation of hinge region (J. Vlasak et al 2007) Important role on function and stability IGG1 4
5 Introduction Analytical approaches Free thiols: - Reversed Phase Chromatography - Derivatization of free thiols with fluorimetric detection - Tryptic peptide map after derivatization of free thiols sum of all free thiols site-specific percentage of open disulfide bonds Incorrect disulfide pairing: - ESI-MS - Tryptic peptide map LCMS comparison before/after reduction poor sensitivity for minor species 5
6 Introduction Example 1: bispecific MAB Method description Research Clone Results of a research clone Results of the best producing clone Example 2: MAB with open SH Determination of free thiols Comparison with RP HPLC Determination of incorrect disulfide pairing Conclusions 6
7 Example 1: bispecific MAB Bispecific antibodies: Merge of two antibodies Ridgway JB, et al. (1996) 'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization. Protein Eng 9: Atwell S, et al. (1997) Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library. J. Mol. Biol. 270: desired mainproduct possible sideproduct 7
8 Sample preparation for LCMS peptide map Native tryptic digest (50µg antibody; c>2mg/ml) Alkylation of free SH: Buffer exchange: Digest (combination of LysC and Trypsin): - 1. Step: Addition of MAB : LysC 70:1 MAB : Trypsin 25:1-2.Step: Addition of MAB : Trypsin 25:1 Termination of digestion incubation 2h / 37 C incubation 16h / 37 C 8
9 Data evaluation LC MSMS on Thermo LTQ Orbitrap Top5 LCMSMS method (FT R=30.000; fragmentation in iontrap): Identification of SS-bridged peptides Dbond Algorithm (Seonhwa Choi et al 2009) : - java based software tool which screens all MSMS data to find b-/y- ions of SS bridged peptides - search based on local storage - workflow similar to mascot search (parameter files, modifications, fasta-file, excel export) Quantification by XIC evaluation relative determination of false SS-bridged peptides 9
10 Results: bispecific MAB of a research clone regular tryptic peptide (rel amount: 8%) 10
11 Results: bispecific MAB of a research clone regular tryptic peptide (rel amount: 8%) 11
12 Results: bispecific MAB of a research clone 12
13 Results: bispecific MAB of a research clone 13
14 Results: bispecific MAB of a research clone Int 37% 9% 25% 18% m/z 14
15 Results: bispecific MAB of a research clone 15
16 Results: bispecific MAB of a research clone Int 37% 9% 25% 18% m/z 16
17 Results: bispecific MAB of a research clone 17
18 Results: bispecific MAB of a research clone Quantification by SS bridge HC $ HC Description ratio HC1 366 HC2 343 HC1_$_HC2 88,0 HC2 343 HC2 343 HC2-Dimer 11,4 HC1 366 HC1 366 HC1_Dimer 0,6 18
19 Results: bispecific MAB of a research clone Int 37% 9% 25% 18% m/z 19
20 Results: bispecific MAB of a research clone Quantification by each cysteine SS Bond Description ratio LC1_Cys 213 LC1 213 HC1 232 LC1_$_HC1 27,7 LC1 213 HC2 214 LC1_$_HC2 49,6 LC1 213 LC1 213 LC1-Dimer 22,6 LC1 213 LC2 226 LC1_$_LC2 0,1 20
21 Results: bispecific MAB of a research clone Quantification by each cysteine SS Bond Description ratio LC1_Cys 213 LC1 213 HC1 232 LC1_$_HC1 27,7 LC1 213 HC2 214 LC1_$_HC2 49,6 LC1 213 LC1 213 LC1-Dimer 22,6 LC1 213 LC2 226 LC1_$_LC2 0,1 21
22 Results: bispecific MAB of a research clone RT: 4,17-9, ,83 TIC of native digest NL: 7,90E7 TIC F: ms MS f ,27 5,56 6,15 8,37 6,57 4,49 5,82 5,26 6,41 7,44 4,85 5,14 7,11 7,55 7,99 8,11 8,64 8,74 9,16 7,08 XIC of SS-peptide NL: 2,80E4 m/z= 507,18-507,21 F: ms MS f ,85 4,28 5,98 6,58 4,33 7,44 5,09 4,48 5,28 5,70 4,55 4,86 6,46 8,11 8,27 5,38 6,40 7,18 7,57 7,99 8,45 8,79 9,05 9,21 4,77 6,54 6,85 7,08 7,37 TIC of reduced digest XIC of SS-peptide NL: 2,69E7 TIC MS f NL: 7,36E2 m/z= 507,18-507,21 MS f ,5 5,0 5,5 6,0 6,5 7,0 7,5 8,0 8,5 9,0 Time (min) 22
23 Results: bispecific MAB of a research clone RT: 4,17-9, ,83 TIC of native digest NL: 7,90E7 TIC F: ms MS f ,27 5,56 6,15 8,37 6,57 4,49 5,82 5,26 6,41 7,44 4,85 5,14 7,11 7,55 7,99 8,11 8,64 8,74 9,16 7,08 XIC of SS-peptide NL: 2,80E4 m/z= 507,18-507,21 F: ms MS f ,85 4,28 5,98 6,58 4,33 7,44 5,09 4,48 5,28 5,70 4,55 4,86 6,46 8,11 8,27 5,38 6,40 7,18 7,57 7,99 8,45 8,79 9,05 9,21 4,77 6,54 6,85 7,08 7,37 TIC of reduced digest NL: 2,69E7 TIC MS f NL: 7,36E2 m/z= 507,18-507,21 MS f ,5 5,0 5,5 6,0 6,5 7,0 7,5 8,0 8,5 9,0 Time (min) 23
24 Introduction Example 1: bispecific MAB Method description Research Clone Results of a research clone Results of the best producing clone Example 2: MAB with open SH Determination of free thiols Comparison with RP HPLC Determination of incorrect disulfide pairing Conclusions 24
25 Results: Bispecific MAB of best producing clone - No incorrect disulfide linkages detected! - Disulfide linkages covered except for: peptides > 7000 Da (bad CID fragmentation data) peptide with two SS linkages peptide due to incomplete digest incomplete digest 25
26 Introduction Example 1: bispecific MAB Method description Research Clone Results of a research clone Results of the best producing clone Example 2: MAB with open SH Determination of free thiols Comparison with RP HPLC Determination of incorrect disulfide pairing Conclusions 26
27 Sample preparation In-house optimized reduced tryptic pepmap by derivatization with NEM/NEM-d5 0µg antibody; c>2mg/ml) Derivatization free SH with NEM Buffer Exchange to remove NEM Label concentrate by centrifugation Reduction of linked disulfides Derivatization of ne novo formed thiols with NEM-d5: Buffer Exchange to remove NEM-d5 Label Tryptic Digest Termination of Digestion 27
28 Example 2: Determination of free thiols C265 C230 C233 Peptid N NEM-d5 [%] N NEM [%] N SH [%] Peptid N NEM-d5 [%] N NEM [%] N SH [%] C22 65,59 34,41 n.n. C96 64,27 35,73 n.n. C149 H12 97,04 2,73 0,23 C204 99,65 n.n. 0,35 C224 99,42 0,58 n.n. C218 n.n. n.n. n.n. C230/ n.n. n.n. C230/ n.n. n.n. C265 94,83 4,9 0,27 C325 n.n. n.n. n.n. C371 95,43 4,39 0,18 C429 96,6 3,28 0,12 C23 96,78 3,14 0,08 C n.n. n.n. C n.n. n.n. C198 99,49 0,47 0,04 C325 C371 C429 28
29 Example 2: comparison with RP HPLC Ratio of free thiol LCMS ca 36% 41% 46% 13% calculated probability based on LCMS data 29
30 Example 2: Determination of incorrect disulfide pairing NEM-Tag C230 C233 SS Bond Description Ratio ph 7 C22 NEM HC_$_NEM 31.5 C22 C96 HC_$_HC 56.5 C22 C198 HC_$_LC 1.4 C22 C265 HC_$_LC 3.9 C22 minor species 3.0 C265 C325 C371 C429 30
31 Example 2: Determination of incorrect disulfide pairing NEM-Tag SS Bond Description Ratio ph 7 C96 NEM HC_$_NEM 47.4 C96 C22 HC_$_HC 48.7 C230 C233 C96 C265 HC_$_LC 1.6 C96 C371 HC_$_LC 1.0 C96 minor species 1.3 C265 C325 C C429
32 Introduction Example 1: bispecific MAB Method description Research Clone Results of a research clone Results of the best producing clone Example 2: MAB with open SH Determination of free thiols Comparison with RP HPLC Determination of incorrect disulfide pairing Conclusions 32
33 Conclusion Disulfide mismatching Native Tryptic Pepmap Evaluation by DBond - highly sensitive method to identify minor species of incorrect disulfide pairing - complex evaluation not practical for high troughput applications - induced scrambling during basic tryptic digest ESI-MS - high troughput application - not sensitive to minor species Free thiols - RP HPLC results correlate with tryptic peptide map with NEM/ NEM-d5 derivatization - tryptic peptide map with NEM/ NEM-d5 derivatization appropriate for identification of low ratios of free thiols
34 Acknoledgements Eunok Paek (University of Soeul; Dbond Algortithm) Nadja Alt Dietmar Reusch Nadine Flöser Manuel Schott Ingo Linder Andreas Adler
35 Doing now what patients need next 35
36 Example 2: Determination of Incorrect Disulfide Pairing Influence of Digest conditions C22 Label Area ph8,5 Area ph7 Area ph6 [%] [%] [%] HC_C96 30,1 56,5 52,5 HC_C265 12,1 3,9 0,8 LC_C198 14,2 1,4 0,2 HC_C148 13,4 0,9 0,1 LC_C138 9,8 0,8 0,1 HC_C325 2,6 0,6 0,1 HC_C371 5,5 0,3 0,1 LC_C23 5,3 0,2 0,0 HC_C22 1,1 0,2 0,0 HC_C224 1,3 0,1 0,0 HC_C429 1,0 0,0 0,0 LC_C92 1,0 0,0 0,0 HC_C204 0,3 0,0 0,0 NEM 2,1 35,1 46,1 C96 Label Area ph8,5 Area ph7 Area ph6 [%] [%] [%] HC_C22 36,8 48,7 34,0 HC_C265 7,3 1,6 0,6 HC_C371 10,9 1,0 0,2 LC_C198 15,7 0,4 0,1 LC_C138 4,0 0,4 0,0 HC_C325 2,6 0,3 0,0 HC_C148 6,8 0,2 0,1 HC_C429 7,4 0,0 0,0 HC_C224 1,4 0,0 0,0 HC_C96 0,6 0,0 0,0 HC_C204 0,4 0,0 0,0 NEM 6,3 47,4 64,9 36
37 ph 6.0 ph 7.0 ph 8.5 ph 6.0 ph 7.0 ph 8.5 ph 7.0 Compare of digest conditions MAB A native MAB B native MAB C native MAB D reduced kda kda
Highly Confident Peptide Mapping of Protein Digests Using Agilent LC/Q TOFs
Technical Overview Highly Confident Peptide Mapping of Protein Digests Using Agilent LC/Q TOFs Authors Stephen Madden, Crystal Cody, and Jungkap Park Agilent Technologies, Inc. Santa Clara, California,
More informationUtilizing novel technology for the analysis of therapeutic antibodies and host cell protein contamination
Utilizing novel technology for the analysis of therapeutic antibodies and host cell protein contamination Kelli Jonakin, Ph.D. Senior Field Application Scientist, Seattle, WA Eric Johansen, Ph.D. Senior
More informationAnalysis of Monoclonal Antibodies and Their Fragments by Size-Exclusion Chromatography Coupled with an Orbitrap Mass Spectrometer
Analysis of Monoclonal Antibodies and Their Fragments by ize-exclusion Chromatography Coupled with an Orbitrap Mass pectrometer hanhua Lin, Hongxia Wang, Zhiqi Hao, and Xiaodong Liu Thermo Fisher cientific,
More informationProteinPilot Report for ProteinPilot Software
ProteinPilot Report for ProteinPilot Software Detailed Analysis of Protein Identification / Quantitation Results Automatically Sean L Seymour, Christie Hunter SCIEX, USA Powerful mass spectrometers like
More informationMonoclonal Antibody Characterization on Q Exactive and Oribtrap Elite. Yi Zhang, Ph.D Senior Proteomic Marketing Specialist Oct.
Monoclonal Antibody Characterization on Q Exactive and Oribtrap Elite Yi Zhang, Ph.D Senior Proteomic Marketing Specialist Oct. 12, 211 Outline Orbitrap Mass Spectrometer in mab Characterization Intact
More informationAnalysis of Monoclonal Antibodies and Their Fragments by Size Exclusion Chromatography Coupled with an Orbitrap Mass Spectrometer
Analysis of Monoclonal Antibodies and Their Fragments by Size Exclusion Chromatography Coupled with an Orbitrap Mass Spectrometer Shanhua Lin, 1 Hongxia Wang, 2 Zhiqi Hao, 2 Patrick Bennett, 2 and Xiaodong
More informationBasic protein and peptide science for proteomics. Henrik Johansson
Basic protein and peptide science for proteomics Henrik Johansson Proteins are the main actors in the cell Membranes Transport and storage Chemical factories DNA Building proteins Structure Proteins mediate
More informationEnsure your Success with Agilent s Biopharma Workflows
Ensure your Success with Agilent s Biopharma Workflows Steve Madden Software Product Manager Agilent Technologies, Inc. June 5, 2018 Agenda Agilent BioPharma Workflow Platform for LC/MS Intact Proteins
More informationProMass HR Applications!
ProMass HR Applications! ProMass HR Features Ø ProMass HR includes features for high resolution data processing. Ø ProMass HR includes the standard ProMass deconvolution algorithm as well as the full Positive
More informationBiotherapeutic Non-Reduced Peptide Mapping
Biotherapeutic Non-Reduced Peptide Mapping Routine non-reduced peptide mapping of biotherapeutics on the X500B QTOF System Method details for the routine non-reduced peptide mapping of a biotherapeutic
More informationFast and Efficient Peptide Mapping of a Monoclonal Antibody (mab): UHPLC Performance with Superficially Porous Particles
Fast and Efficient Peptide Mapping of a Monoclonal Antibody (mab): UHPLC Performance with Superficially Porous Particles Application Note Biotherapeutics and Biosimilars Authors James Martosella, Alex
More informationSpectral Counting Approaches and PEAKS
Spectral Counting Approaches and PEAKS INBRE Proteomics Workshop, April 5, 2017 Boris Zybailov Department of Biochemistry and Molecular Biology University of Arkansas for Medical Sciences 1. Introduction
More informationADVANCING ATTRIBUTE CONTROL OF ANTIBODIES AND ITS DERIVATIVES USING HIGH RESOLUTION ANALYTICS
ADVANCING ATTRIBUTE CONTROL OF ANTIBODIES AND ITS DERIVATIVES USING HIGH RESOLUTION ANALYTICS Henry Shion 1, Jing Fang 1, William Alley 1, Barbara Sullivan 2, Nick Tomczyk 3, Liuxi Chen 1, Ying-Qing Yu
More informationThe Peptide Mapping Games!
The Peptide Mapping Games! Introduction and Manual Sample Prep CSD Tim Rice, Paul Dinsmoor BioColumn Technical Specialists 1 Proteins and Monoclonal Antibodies Complex Molecules, Complex Manufacturing
More informationPAVING THE WAY FOR ASSESSING IN VIVO DYNAMICS OF MULTIPLE QUALITY ATTRIBUTES FOR PROTEIN THERAPEUTICS
PAVING THE WAY FOR ASSESSING IN VIVO DYNAMICS OF MULTIPLE QUALITY ATTRIBUTES FOR PROTEIN THERAPEUTICS CASSS Mass Spec September 21, 2017 Haihong Zhou Principal Scientist, Biologics, Vaccines & Bioanalytics
More informationAdvanced QA/QC characterization MS in QC : Multi Attribute Method
Advanced QA/QC characterization MS in QC : Multi Attribute Method Global BioPharma Summit The world leader in serving science A Complex Problem: Drug Safety and Quality Safety Is the product safe to use?
More informationSupplementary Table 1: List of CH3 domain interface residues in the first chain (A) and
Supplementary Tables Supplementary Table 1: List of CH3 domain interface residues in the first chain (A) and their side chain contacting residues in the second chain (B) a Interface Res. in Contacting
More informationmabs and ADCs analysis by RP
mabs and ADCs analysis by RP Shanhua Lin, Ph.D. The world leader in serving science Protein and mab Separation by HPLC Size difference? YES Size Exclusion Chromatography (SEC) MAbPac SEC-1 NO NO Charge
More informationChromatographic Workflows for Biopharmaceutical Characterization
Chromatographic Workflows for Biopharmaceutical Characterization Dr. Ken Cook European Bioseparation Sales Support Expert Thermo Fisher Scientific, Hemel Hempstead/Germany The world leader in serving science
More informationRapid Peptide Mapping via Automated Integration of On-line Digestion, Separation and Mass Spectrometry for the Analysis of Therapeutic Proteins
Rapid Peptide Mapping via Automated Integration of On-line Digestion, Separation and Mass Spectrometry for the Analysis of Therapeutic Proteins Esther Lewis, 1 Kevin Meyer, 2 Zhiqi Hao, 1 Nick Herold,
More informationZipChip TM. Microfluidic CE-ESI Biotherapeutics CE-ESI-MS Applications. Please visit us at
ZipChip TM Microfluidic CE-ESI Biotherapeutics CE-ESI-MS Applications Please visit us at http://www.908devices.com/ // Actionable Intelligence HPMS & On-board Analytics / Slide 1 June 2016 // ZipChip CE-ESI
More informationProteins. Patrick Boyce Biopharmaceutical Marketing Manager Waters Corporation 1
Routine Characterization of mabs and Other Proteins Patrick Boyce Biopharmaceutical Marketing Manager Europe and India 2011 Waters Corporation 1 Agenda Why? What scientific challenges? Technology Example
More informationJohn Mehl, Bogdan Sleczka, Eugene Ciccimaro, Christian Caporuscio, Ekaterina Deyanova, Richard Huang, Timothy Olah, Celia D Arienzo
Bioanalytical strategies for the quantitation of in-vivo site specific modifications of therapeutic antibodies in early discovery cyno studies using IP-LC-MS John Mehl, Bogdan Sleczka, Eugene Ciccimaro,
More informationHost Cell Protein Analysis Using Agilent AssayMAP Bravo and 6545XT AdvanceBio LC/Q-TOF
Application Note Biotherapeutics and Biosimilars Host Cell Protein Analysis Using Agilent AssayMAP Bravo and 6545XT AdvanceBio LC/Q-TOF Authors Linfeng Wu, Shuai Wu and Te-Wei Chu Agilent Technologies,
More informationApplication Note. Authors. Abstract. Ravindra Gudihal Agilent Technologies India Pvt. Ltd. Bangalore, India
Quantitation of Oxidation Sites on a Monoclonal Antibody Using an Agilent 1260 Infinity HPLC-Chip/MS System Coupled to an Accurate-Mass 6520 Q-TOF LC/MS Application Note Authors Ravindra Gudihal Agilent
More informationBIOSIMILAR PROFILING SUMMER 2018 ANDREA DETLEFSEN
BIOSIMILAR PROFILING SUMMER 2018 ANDREA DETLEFSEN PROTEIN DRUGS Therapeutic proteins are one of the fastest growing categories of pharmaceuticals Ex: mabs, recombinant proteins As patents expire, biosimilars
More informationComparability Analysis of Protein Therapeutics by Bottom-Up LC-MS with Stable Isotope-Tagged Reference Standards
Comparability Analysis of Protein Therapeutics by Bottom-Up LC-MS with Stable Isotope-Tagged Reference Standards 16 September 2011 Abbott Bioresearch Center, Worcester, MA USA Manuilov, A. V., C. H. Radziejewski
More informationWorkflows for the Characterization of Glycan structure on Biotherapeutics
New Innovations in UHPLC and LC-MS Workflows for the Characterization of Glycan structure on Biotherapeutics Ken Cook EU Bio-Separations Support Expert April 2015 1 The world leader in serving science
More informationA Complete Workflow Solution for Intact Monoclonal Antibody Characterization Using a New High-Performance Benchtop Quadrupole- Orbitrap LC-MS/MS
A Complete Workflow Solution for Intact Monoclonal Antibody Characterization Using a New High-Performance Benchtop Quadrupole- Orbitrap LC-MS/MS Zhiqi Hao, 1 Yi Zhang, 1 David Horn, 1 Seema Sharma, 1 Shiaw-Lin
More informationQuantification of Host Cell Protein Impurities Using the Agilent 1290 Infinity II LC Coupled with the 6495B Triple Quadrupole LC/MS System
Application Note Biotherapeutics Quantification of Host Cell Protein Impurities Using the Agilent 9 Infinity II LC Coupled with the 6495B Triple Quadrupole LC/MS System Authors Linfeng Wu and Yanan Yang
More informationCharacterization of intact monoclonal antibody with microfluidic chip electrophoresis mass spectrometry
POSTER NOTE 65 Characterization of intact monoclonal antibody with microfluidic chip electrophoresis mass spectrometry Authors Chien-Hsun Chen, 1 Andreas Krupke, 2 Stephane Houel, 1 Aaron Bailey, 1 Aran
More informationStrategies in proteomics
Strategies in proteomics Systems biology - understand cellpathways, network, and complex interacting (includes Genomics, Proteomics, Metabolomics..) Biological processes - characterize protein complexes,
More informationSimple, Robust, High Quality Intact Mass Analysis A Biosimilars Case Study
3 Conjugation Site (ADC) 4 34 35 1 1 35 34 CASE STUDY 3 National Institute for Bioprocessing 3 4 Research and Training 1 35 31 5 31 3 6 9 3 9 5 6 7 7 6 8 8 3 1 19 16 17 19 18 7 9 11 11 5 17 9 7 3 1 9 9
More informationBioConfirm B Presentation
BioConfirm B.08.00 Presentation 1 Major Enhancements to Increase Your Productivity The Latest Version of our BioConfirm Product, B.08.00 BioConfirm is protein and peptide characterization software using
More informationThe world leader in serving science. Jonathan L. Josephs and Aaron O. Bailey. Life Sciences Mass Spectrometry
Characterization of Monoclonal Antibodies Using UHPLC-HRAM MS The power of the Q Exactive BioPharma for online intact, subunit analysis, middle down, and peptide mapping Jonathan L. Josephs and Aaron O.
More informationA High Resolution Bench-Top Orbitrap LC-MS Workflow Solution for Comprehensive Intact Monoclonal Antibody Characterization
A High Resolution Bench-Top Orbitrap LC-MS Workflow Solution for Comprehensive Intact Monoclonal Antibody Characterization Zhiqi Hao, 1 David M. Horn, 1 Shiaw-Lin Wu, 2 Fan Zhang, 2 and Patrick Bennett
More informationComprehensive characterization of three IgG forms using CESI-MS
Comprehensive characterization of three IgG forms using CESI-MS Bryan Fonslow 1, Olga V. Friese 2, and K. Steven Cook 2 1 SCIEX, Brea, CA and 2 Pfizer, Chesterfield, MO mabs, ADCs, biosimilars, and biobetters
More information基于质谱的蛋白质药物定性定量分析技术及应用
基于质谱的蛋白质药物定性定量分析技术及应用 蛋白质组学质谱数据分析 单抗全蛋白测序及鉴定 Bioinformatics Solutions Inc. Waterloo, ON, Canada 上海 中国 2017 1 3 PEAKS Studio GUI Introduction Overview of PEAKS Studio GUI Project View Tasks, running info,
More informationAlgorithm for Matching Additional Spectra
Improved Methods for Comprehensive Sample Analysis Using Protein Prospector Peter R. Baker 1, Katalin F. Medzihradszky 1 and Alma L. Burlingame 1 1 Mass Spectrometry Facility, Dept. of Pharmaceutical Chemistry,
More informationLiver Mitochondria Proteomics Employing High-Resolution MS Technology
Liver Mitochondria Proteomics Employing High-Resolution MS Technology Jenny Ho, 1 Loïc Dayon, 2 John Corthésy, 2 Umberto De Marchi, 2 Antonio Núñez, 2 Andreas Wiederkehr, 2 Rosa Viner, 3 Michael Blank,
More informationInvestigating Biological Variation of Liver Enzymes in Human Hepatocytes
Investigating Biological Variation of Liver Enzymes in Human Hepatocytes SWATH Acquisition on the TripleTOF Systems Xu Wang 1, Hui Zhang 2, Christie Hunter 1 1 SCIEX, USA, 2 Pfizer, USA MS/MS ALL with
More informationBiotherapeutic Peptide Mapping Information Dependent Acquisition (IDA) Method
Biotherapeutic Peptide Mapping Information Dependent Acquisition (IDA) Method Routine biotherapeutic accurate mass peptide mapping analysis on the X500B QTOF System Method details for the routine peptide
More informationChallenges in peptide mapping mass spectrometry of biopharmaceuticals
Challenges in peptide mapping mass spectrometry of biopharmaceuticals Will Burkitt, Ben Holmes, Johanna Paris, Nisha Patel, John O Hara 07.MAR.2018 Characterisation within UCB 2 Context to the type of
More informationThermo Scientific Peptide Mapping Workflows. Upgrade Your Maps. Fast, confident and more reliable peptide mapping.
Thermo Scientific Peptide Mapping Workflows Upgrade Your Maps Fast, confident and more reliable peptide mapping. Smarter Navigation... Peptide mapping is a core analytic in biotherapeutic development.
More informationDisulfide Linkage Analysis of IgG1 using an Agilent 1260 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column
Disulfide Linkage Analysis of IgG1 using an Agilent 126 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column Application Note Biotherapeutics & Biosimilars Author M. Sundaram
More informationColumns for Biomolecules BioLC Column Lines
Columns for Biomolecules BioLC Column Lines Monoclonal Antibodies Glycans GlycanPac Nucleic Acids DNAPac Protein A Accucore Amide-HILIC DNAPac PA1 SEC-1 GlycanPac AXH-1 DNAPac PA2 SCX-1 GlycanPac AXR-1
More informationIRDye Infrared Dye Reagents
IRDye Infrared Dye Reagents Technical Note IRDye 680LT Maleimide Labeling Application Guide Published March 2010. The most recent version of this Technical Note is posted at http://biosupport.licor.com/support
More informationProfiling Glycosylation of Monoclonal Antibodies at Three Levels Using the Agilent 6545XT AdvanceBio LC/Q TOF
Application Note Biotherapeutics and Biosimilars Profiling Glycosylation of Monoclonal Antibodies at Three Levels Using the Agilent 64XT AdvanceBio LC/Q TOF Author David L. Wong Agilent Technologies, Inc.
More informationPhi29 Scaffold Has a Helix-Loop-Helix Motif and a Disordered Tail. Marc C Morais et al., Nature Structural Biology 2003
Phi29 Scaffold Has a Helix-Loop-Helix Motif and a Disordered Tail Marc C Morais et al., Nature Structural Biology 2003 Free scaffold 13+ 10 min 3 min 1 min 40 sec 100 % 0 100 % 0 100 % 0 100 % 0 Partially
More informationIMPROVE SPEED AND ACCURACY OF MONOCLONAL ANTIBODY BIOANALYSIS USING NANOTECHNOLOGY AND LCMS
IMPROVE SPEED AND ACCURACY OF MONOCLONAL ANTIBODY BIOANALYSIS USING NANOTECHNOLOGY AND LCMS As scientists gain an advanced understanding of diseases at the molecular level, the biopharmaceutical industry
More informationQuantitative mass spec based proteomics
Quantitative mass spec based proteomics Tuula Nyman Institute of Biotechnology tuula.nyman@helsinki.fi THE PROTEOME The complete protein complement expressed by a genome or by a cell or a tissue type (M.
More informationCharacterization of a fusion protein under native and denaturing conditions with maxis II
Characterization of a fusion protein under native and denaturing conditions with maxis II Abstract The maxis II UHR-QTOF was used to characterize key attributes of a fusion protein in its native conformation
More informationPLRP-S Polymeric Reversed-Phase Column for LC/MS Separation of mabs and ADC
PLRP-S Polymeric Reversed-Phase Column for LC/MS Separation of mabs and ADC Analysis of Intact and Fragmented mabs and ADC Application Note Biotherapeutics and Biologics Author Suresh Babu C.V. Agilent
More informationStrategies for Quantitative Proteomics. Atelier "Protéomique Quantitative" La Grande Motte, France - June 26, 2007
Strategies for Quantitative Proteomics Atelier "Protéomique Quantitative", France - June 26, 2007 Bruno Domon, Ph.D. Institut of Molecular Systems Biology ETH Zurich Zürich, Switzerland OUTLINE Introduction
More informationObjective. Introduction. IP assisted LC/MS/MS making study protein complexes easy. Jon Hao 1, Yi Liu 1, Xiaozhi Ren 2, and King-Wai Yau 2
IP assisted LC/MS/MS making study protein complexes easy Jon Hao 1, Yi Liu 1, Xiaozhi Ren 2, and King-Wai Yau 2 1 Poochon Scientific, Frederick, Maryland 21701 2 Department of Neuroscience, Johns Hopkins
More informationiprg-2016 Proteome Informatics Research Group Study: Inferring Proteoforms from Bottom-up Proteomics Data
iprg-2016 Proteome Informatics Research Group Study: Inferring Proteoforms from Bottom-up Proteomics Data The ABRF iprg Research Group October 10, 2016 Dear iprg 2016 Study Participant, Thank you for participating
More informationA Highly Accurate Mass Profiling Approach to Protein Biomarker Discovery Using HPLC-Chip/ MS-Enabled ESI-TOF MS
Application Note PROTEOMICS METABOLOMICS GENOMICS INFORMATICS GLYILEVALCYSGLUGLNALASERLEUASPARG CYSVALLYSPROLYSPHETYRTHRLEUHISLYS A Highly Accurate Mass Profiling Approach to Protein Biomarker Discovery
More informationApplication Note LCMS-87 Automated Acquisition and Analysis of Data for Monitoring Protein Conjugation by LC-MS Using BioPharma Compass
Application Note LCMS-87 Automated Acquisition and Analysis of Data for Monitoring Protein Conjugation by LC-MS Using BioPharma Compass Abstract Here we describe the development and use of an automated
More informationSupplementary information, Figure S1A ShHTL7 interacted with MAX2 but not another F-box protein COI1.
GR24 (μm) 0 20 0 20 GST-ShHTL7 anti-gst His-MAX2 His-COI1 PVDF staining Supplementary information, Figure S1A ShHTL7 interacted with MAX2 but not another F-box protein COI1. Pull-down assays using GST-ShHTL7
More informationBioanalytical LC-MS of monoclonal antibody therapeutics
Bioanalytical LC-MS of monoclonal antibody therapeutics William D van Dongen, product manager pharma bioanalysis small molecules immunogenicity 40 years experience in bioanalysis Bioanalytical Expertise
More informationMass Spectrometry and Proteomics - Lecture 6 - Matthias Trost Newcastle University
Mass Spectrometry and Proteomics - Lecture 6 - Matthias Trost Newcastle University matthias.trost@ncl.ac.uk Previously Quantitation techniques Label-free TMT SILAC Peptide identification and FDR 194 Lecture
More informationAdvanced Characterization of Antibody Drug Conjugates (ADCs) by Liquid Chromatography and Mass Spectrometry (LC/MS) John Gebler, Ph.D.
Advanced Characterization of Antibody Drug Conjugates (ADCs) by Liquid Chromatography and Mass Spectrometry (LC/MS) John Gebler, Ph.D. Director www.waters.com/adc 2015 Waters Corporation 1 2015 Waters
More informationDemonstrating Biosimilarity of a Therapeutic Protein Product to a Reference Product ICH Guidance
Demonstrating Biosimilarity of a Therapeutic Protein Product to a Reference Product ICH Guidance Derek Bradley M.Sc. BioClin Research Laboratories 13 th May 2016 Agenda Brief overview of biosimilars ICH
More informationTowards an in vivo Stability Assay for ADCs and Their Metabolites in Serum by Affinity Capture LC-MS
Towards an in vivo Stability Assay for ADCs and Their Metabolites in Serum by Affinity Capture LC-MS mz (@Dr_mz13), PhD 11-Feb-2013 One of the challenges of ADCs includes the development of a method to
More informationNon-covalent or Native Mass Spectrometry. We can ionize intact protein complexes using ESI!!
Non-covalent or Native Mass Spectrometry We can ionize intact protein complexes using ESI!! What Can We Learn? Stoichiometry of complex Relative affinity and topology Rates of subunit exchange Assembly
More informationUse of a Label-Free Quantitative Platform Based on MS/MS Average TIC to Calculate Dynamics of Protein Complexes in Insulin Signaling
ABRF 2009 SELECTED PRESENTATIONS Use of a Label-Free Quantitative Platform Based on MS/MS Average TIC to Calculate Dynamics of Protein Complexes in Insulin Signaling Xuemei Yang, 1 Adam Friedman, 2 Shailender
More informationHigh Resolution Accurate Mass Peptide Quantitation on Thermo Scientific Q Exactive Mass Spectrometers. The world leader in serving science
High Resolution Accurate Mass Peptide Quantitation on Thermo Scientific Q Exactive Mass Spectrometers The world leader in serving science Goals Explore the capabilities of High Resolution Accurate Mass
More informationIncreasing Throughput and Efficiency with Exactive LC/MS and Triple Quadrupole LC/MS/MS
Increasing Throughput and Efficiency with Exactive LC/MS and Triple Quadrupole LC/MS/MS Nicholas Duczak Thermo Scientific Annual Mass Spectrometry Users Meeting Somerset, NJ October 12th, 2011 Lead Finding
More informationShotgun Proteomics: How Confident are you in that Identification? or Statistical Evaluation of Shotgun Proteomic Data
Shotgun Proteomics: How Confident are you in that Identification? or Statistical Evaluation of Shotgun Proteomic Data Ron Orlando Complex Carbohydrate Research Center University of Georgia Athens, GA 30602
More informationEasy Enhancements via Column Chemistry and Simplified Sample Preparation for Biosimilars. Joann Purkerson Thermo Fisher Scientific
Easy Enhancements via Column Chemistry and Simplified Sample Preparation for Biosimilars Joann Purkerson Thermo Fisher Scientific 1 Biopharma Analysis Workflows Discovery Development HRAM Identification
More informationSimultaneous Quantitation of a Monoclonal Antibody and Two Proteins in Human Plasma by High Resolution and Accurate Mass Measurements
Simultaneous Quantitation of a Monoclonal Antibody and Two Proteins in Human Plasma by High Resolution and Accurate Mass Measurements Paul-Gerhard Lassahn 1, Kai Scheffler 2, Myriam Demant 3, Nathanael
More informationKey questions of proteomics. Bioinformatics 2. Proteomics. Foundation of proteomics. What proteins are there? Protein digestion
s s Key questions of proteomics What proteins are there? Bioinformatics 2 Lecture X roteomics How much is there of each of the proteins? - Absolute quantitation - Stoichiometry What (modification/splice)
More informationSasidhar N. Nirudodhi, Lin Tzihsuan, Justin Sperry, Jason C. Rouse, James A. Carroll
Impact of Sequence Variants on the Higher-Order Structure (HOS) of Monoclonal Antibodies Using an Optimized HDX- MS Method with a Dual-Protease Co-Immobilized Column Format Sasidhar N. Nirudodhi, Lin Tzihsuan,
More informationAdvantages of Ion Mobility QTOF for Characterization of BioPharma Molecules
Advantages of Ion Mobility QTOF for Characterization of BioPharma Molecules Add a New Dimension to your Research Capability with Agilent s New Drift Ion Mobility QTOF System David Wong, Ph.D. Sr. Application
More informationMonoclonal Antibody Analysis on a Reversed-Phase C4 Polymer Monolith Column
Monoclonal Antibody Analysis on a Reversed-Phase C4 Polymer Monolith Column Shane Bechler 1, Ken Cook 2, and Kelly Flook 1 1 Thermo Fisher Scientific, Sunnyvale, CA, USA; 2 Thermo Fisher Scientific, Runcorn,
More informationN-Glycan Profiling Analysis of a Monoclonal Antibody Using UHPLC/FLD/Q-TOF
N-Glycan Profiling Analysis of a Monoclonal Antibody Using UHPLC/FLD/Q-TOF Application Note Authors Xianming Liu, Wei Zhang, Yi Du, Sheng Yin, Hong Que, and Weichang Zhou WuXi AppTec iopharmaceuticals
More informationByos. A Clear Sky Solution for Analytical Scientists
A Clear Sky Solution for Analytical Scientists One-touch Platform to Launch Seamless Workflows Raw File Report in Minutes Integrated application with templated workflows Workflows Step 1: Click to launch
More informationRockerBox. Filtering massive Mascot search results at the.dat level
RockerBox Filtering massive Mascot search results at the.dat level Challenges Big experiments High amount of data Large raw and.dat files (> 2GB) How to handle our results?? The 2.2 peptide summary could
More informationBarry Boyes 1,2, Tim Langlois 1, Brian Wagner 1, Stephanie Schuster 1 and Joe DeStefano 1
Barry Boyes 1,2, Tim Langlois 1, Brian Wagner 1, Stephanie Schuster 1 and Joe DeStefano 1 1. Advanced Materials Technology, Inc. Wilmington, Delaware, USA bboyes@advanced-materials-tech.com 2. Complex
More informationVyužití cílené proteomiky pro kontrolu falšování potravin: identifikace peptidových markerů v mase pomocí LC- Q Exactive MS/MS
Využití cílené proteomiky pro kontrolu falšování potravin: identifikace peptidových markerů v mase pomocí LC- Q Exactive MS/MS Michal Godula Ph.D. Thermo Fisher Scientific The world leader in serving science
More informationAgilent MassHunter BioConfirm Software NEW FRONTIERS IN THE CHARACTERIZATION OF BIOMOLECULES
Agilent MassHunter BioConfirm oftware NEW FRONTIER IN THE CHARACTERIZATION OF BIOMOLECULE NEW WORKFLOW FOR INTACT PROTEIN AND PROTEIN DIGET Biopharmaceutical discovery and development labs demand speed
More informationGenerating Automated and Efficient LC/MS Peptide Mapping Results with the Biopharmaceutical Platform Solution with UNIFI
with the Biopharmaceutical Platform Solution with UNIFI Vera B. Ivleva, Ying Qing Yu, Scott Berger, and Weibin Chen Waters Corporation, Milford, MA, USA A P P L I C AT ION B E N E F I T S The ability to
More informationUniversal Solution for Monoclonal Antibody Quantification in Biological Fluids Using Trap-Elute MicroLC-MS Method
Universal Solution for Monoclonal Antibody Quantification in Biological Fluids Using Trap-Elute MicroLC-MS Method Featuring the SCIEX QTRAP 6500+ LC-MS/MS System with OptiFlow Turbo V source and M5 MicroLC
More informationSupplementary Figures
Supplementary Figures Supplementary Figure 1. FANCD2 Western blot. Lane 1 marker, lane 2 LN9SV, lane 3 LN9SV treated with hydroxyurea (HU), lane 4 GM6914, lane 5 GM6914 treated with HU, lane 6 VU697L,
More informationAsish Chakraborty, St John Skilton, Weibin Chen and John C. Gebler Waters Corporation, Milford, MA, U.S. INTRODUCTION METHODS. Sample preparation
Com p r e h ensiv e a n d Rou t in e C ha r ac t e riz at io n o f P rot eins a n d P e p t i d e s by LC/MS and LC/MS E Asish Chakraborty, St John Skilton, Weibin Chen and John C. Gebler Waters Corporation,
More informationMulti-Enzyme Digestion for Biotherapeutic Peptide Mapping: Examining BiopharmaLynx 1.3 Functionality
Multi-Enzyme Digestion for Biotherapeutic Peptide Mapping: Examining BiopharmaLynx 1.3 Functionality Scott J. Berger Waters Corporation, Milford, MA, USA TECHNOLOGY BENEFITS Enabling advanced multi-protease
More informationSeparation of Native Monoclonal Antibodies and Identification of Charge Variants:
Separation of Native Monoclonal Antibodies and Identification of Charge Variants: Teamwork of the Agilent 31 OFFGEL Fractionator, Agilent 21 Bioanalyzer and Agilent LC/MS Systems Application Note Biosimilar
More informationApplication Note. Kwasi Antwi, Amanda Ribar, Urban A. Kiernan, and Eric E. Niederkofler Thermo Fisher Scientific, Tempe, Arizona
Analysis of an Antibody Drug Conjugate using MSIA D.A.R.T. S. Technology, an Integral Part of Ligand Binding Mass Spectrometric Immunoassay (LB-MSIA) Workflow Application Note Kwasi Antwi, Amanda Ribar,
More informationA comprehensive CE/ESI-MS solution for BioPharma applications
A comprehensive CE/ESI-MS solution for BioPharma applications Thermo Scientific Q Exactive hybrid quadrupole-orbitrap mass spectrometers with ZipChip system Fast CE Separation Nanospray Sensitivity HRAM
More informationPut the PRO in Protein Characterization
Put the PRO in Protein Characterization Aaron Boice LC/Q-TOF Product Manager 5-June-2017 Agenda The Right Tools for the Job Tackling Intact Proteins Break it Down Peptides and PTMs Sweet Success Released
More informationA highly sensitive and robust 150 µm column to enable high-throughput proteomics
APPLICATION NOTE 21744 Robust LC Separation Optimized MS Acquisition Comprehensive Data Informatics A highly sensitive and robust 15 µm column to enable high-throughput proteomics Authors Xin Zhang, 1
More informationCharge Variant Assessment of Nanobodies at the Intact Level by CESI-MS
Charge Variant Assessment of Nanobodies at the Intact Level by CESI-MS Sensitive workflow for the detection of charge variants of nanobodies from small sample volumes Stephen Lock 1, Rob Haselberg 2, Raimond
More informationAnalytical Characterization of Biotherapeutics: Looking to the Future with Biosimilars
Analytical Characterization of Biotherapeutics: Looking to the Future with Biosimilars Jared Auclair, Ph.D. Northeastern University Department of Chemistry and Chemical Biology Barnett Institute of Chemical
More informationBiochromatography Bring more Zen into your life and laboratory
Seminar Biochromatography Bring more Zen into your life and laboratory Method development and maintaining peptide, protein, glycan and anti-body analyses by LC or LC-MS can be very time consuming and might
More informationFilter-based Protein Digestion (FPD): A Detergent-free and Scaffold-based Strategy for TMT workflows
Supporting Information Filter-based Protein Digestion (FPD): A Detergent-free and Scaffold-based Strategy for TMT workflows Ekaterina Stepanova 1, Steven P. Gygi 1, *, Joao A. Paulo 1, * 1 Department of
More informationEnabling routine characterization of proteins. Agilent MassHunter BioConfirm software
Enabling routine characterization of proteins Agilent MassHunter BioConfirm software Bioconfirm a key component of your major biopharma workflows Intact protein analysis BioConfirm will rapidly deconvolute
More informationApplication Note # ET-20 BioPharma Compass: A fully Automated Solution for Characterization and QC of Intact and Digested Proteins
Application Note # ET-20 BioPharma Compass: A fully Automated Solution for Characterization and QC of Intact and Digested Proteins BioPharma Compass TM is a fully automated solution for the rapid characterization
More informationImproving Sensitivity for an Immunocapture LC-MS Assay of Infliximab in Rat Plasma Using Trap-and-Elute MicroLC-MS
Improving Sensitivity for an Immunocapture LC-MS Assay of in Rat Plasma Using Trap-and-Elute MicroLC-MS Using the SCIEX M3 MicroLC system for Increased Sensitivity in Antibody Quantitation Remco van Soest
More informationZipChip TM. Microfluidic CE-ESI Utility Life Sciences CE-ESI-MS Applications. Please visit us at
ZipChip TM Microfluidic CE-ESI Utility Life Sciences CE-ESI-MS Applications Please visit us at http://www.908devices.com/ // Actionable Intelligence HPMS & On-board Analytics / Slide 1 June 2016 // Presentation
More informationHigh-Throughput Peptide Mapping with the Vanquish UHPLC System and the Q Exactive HF Mass Spectrometer
High-Throughput Peptide Mapping with the Vanquish UHPLC System and the Q Exactive HF Mass Spectrometer Martin Samonig 1, Kai Scheffler 2, Remco Swart 1, and Jonathan Josephs 3 1 Thermo Fisher Scientific,
More information